Remus Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹2,219.95(2.02%)May 16, 2025 15:28:49 PM IST
- NSE
- BSE
- Vol : 8.80K (NSE + BSE)Last 20 day avg : 2.23 K
Remus Pharmaceuticals is trading 2.02% upper at Rs 2,219.95 as compared to its last closing price. Remus Pharmaceuticals has been trading in the price range of 2,279.00 & 2,120.00. Remus Pharmaceuticals has given -12.87% in this year & 17.06% in the last 5 days. Remus Pharmaceuticals has TTM P/E ratio 51.64 as compared to the sector P/E of 23.72.The company posted a net profit of 14.01 Crores in its last quarter.Listed peers of Remus Pharmaceuticals include Yatra Online (-1.60%), Sahana System (5.00%), Remus Pharmaceuticals (2.02%).The Mutual Fund holding in Remus Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Remus Pharmaceuticals was at 4.77% in 31 Mar 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on May 16, 2025, 02:34 PM UTC
- Dividend YieldLower than industry0.05Annual dividends as a percentage of the stock price.
- P/B14.76The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values42.89Price-to-earnings ratio based on trailing 12-month earnings
- Debt To EquityLower than industry0.13The debt-to-equity ratio, indicating a company's financial leverage.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
- R1
- 2,197.27
- R2
- 2,374.13
- R3
- 2,560.27
- S1
- 1,834.27
- S2
- 1,648.13
- S3
- 1,471.27
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Yatra Online | Moderately Bullish | 94.03 | -1.60 | 1,476.41 | - | 1.85 | - | 3.73 |
| Sahana System | Bullish | 1,590.95 | 5.00 | 1,397.70 | 79.07 | 23.76 | - | - |
| Remus Pharmaceuticals | Moderately Bullish | 2,219.95 | 2.02 | 1,307.99 | 60.13 | 14.61 | 0.09 | 3.45 |
| Rossell Techsys | Bullish | 347.70 | 1.99 | 1,310.70 | 111.51 | 9.88 | - | 3.95 |
| Ecos India Mobility & Hospitalit | Neutral | 222.10 | 3.98 | 1,323.92 | 19.88 | 7.01 | - | 7.19 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-17 | Audited Results, Dividend & Others |
| 2024-11-09 | Quarterly Results & Interim Dividend |
| 2024-05-16 | Audited Results |
| 2024-04-23 | Bonus issue & Interim Dividend |
| 2024-04-22 | Interim Dividend |
- Industry
- ISININE0O5T01011
- BSE Code
- NSE CodeREMUS
Remus Pharmaceuticals is trading at 2219.95 as on Fri May 16 2025 09:58:49. This is 2.02% upper as compared to its previous closing price of 2176.00.
The market capitalization of Remus Pharmaceuticals is 1307.99 Cr as on Fri May 16 2025 09:58:49.
The 52 wk high for Remus Pharmaceuticals is 2834.75 whereas the 52 wk low is 1591.25
Remus Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 51.64
- Sector P/E: 23.72
- Dividend Yield: 0.05%
- D/E ratio: 0.21
Remus Pharmaceuticals reported a net profit of 21.54 Cr in 2024.